AI 100
AI資本
AI 業界マップ
AI ETF
言語
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
ログイン / 新規登録
AI 100
AI資本
AI 業界マップ
AI ETF
言語
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
← 投資家一覧に戻る
Capital Group
投资主体(类型未细分)
公式サイト ↗
確認済み投資額の下限
≥$10.03M
投資事例
3
機関設立からの年数
—
代表的な投資事例
Anthropic
$965B
↗
Legora
$8.8B
↗
Insilico Medicine(英矽智能)
$2.65B
↗
投資先一覧
投資先の動向
投資家別の出資
個別ファンド
機関情報
検索
#
企業
時価総額・評価額
USD
累計調達額
USD
最終調達・上場
主な投資家
01
Anthropic
美国
$965B
未公開評価額
2026-05-28
出典 · 1
Anthropic raises $65B Series H at $965B valuation \ Anthropic ↗
2026-10-22
≥$108.45B
確認済みの下限
$65B
Series H
2026-05-28
出典 · 1
Anthropic raises $65B Series H at $965B valuation \ Anthropic ↗
2026-10-22
Altimeter Capital
Dragoneer Investment Group
Greenoaks Capital
Sequoia Capital
Capital Group
Coatue Management
その他の投資家 · 52
D1 Capital
GIC
ICONIQ Capital
XN
D.E. Shaw Ventures
Founders Fund
MGX
Fidelity Investments
Lightspeed Venture Partners
Spark Capital
Amazon
Baillie Gifford
Blackstone
General Catalyst
Insight Partners
Jane Street
T. Rowe Price
AMP PBC
NX1
Temasek
Brookfield
DST Global
NTTVC
Micron
Samsung
SK Hynix
BlackRock
D1
Goldman Sachs Alternatives
Qatar Investment Authority
TPG
Accel
Addition
Alpha Wave
Appaloosa
Bessemer Venture Partners
JPMorgan
Menlo Ventures
Morgan Stanley Investment Management
Sands
TowerBrook
Whale Rock
ARK Invest
General Atlantic
Ontario Teachers
WCM
Google
SK Telecom
Salesforce Ventures
Sound Ventures
Zoom Ventures
LG Technology Ventures
26
Legora
瑞典/美国
$8.8B
未公開評価額
2026-10-21
出典 · 1
Legora raises $550 million Series E at $8.8 billion valuation to accelerate growth - Legora ↗
2026-10-22
≥$1.1B
確認済みの下限
$550M
Series E
2026-10-21
出典 · 1
Legora raises $550 million Series E at $8.8 billion valuation to accelerate growth - Legora ↗
2026-10-22
Atreides Management
Baron Capital
Capital Group
Fidelity Investments
Glade Brook
J.P. Morgan
その他の投資家 · 10
Accel
Benchmark
Bessemer Venture Partners
General Catalyst
ICONIQ Capital
Insight Partners
Menlo Ventures
Redpoint Ventures
Salesforce Ventures
Sands
57
Insilico Medicine(英矽智能)
3696.HK · 美国/中国
$2.65B
上場時価総額
基準日未確認
出典 · 1
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO ↗
2026-10-22
≥$110M
確認済みの下限
IPO・上場
2025-12-30
Value Partners PE Fund
Eli Lilly
Tencent
Oaktree Capital Management
Schroders(施罗德)
Temasek
その他の投資家 · 14
UBS
China Asset Management(华夏基金)
Pacific Asset Management(太平洋资产)
CPIC Investment Management HK
E Fund Management(易方达基金)
Fullgoal Fund Management(富国基金)
Harvest Global Investments(嘉实国际)
Taikang Life Insurance(泰康人寿)
RTW Investments
Exome Asset Management
Infini Capital Management(无极资本)
Capital Group
Mirae Asset Securities Co., Ltd.
OrbiMed Advisors IV Limited